Rani Therapeutics Holdings Inc (NASDAQ: RANI) on Friday, soared 13.82% from the previous trading day, before settling in for the closing price of $0.55. Within the past 52 weeks, RANI’s price has moved between $0.39 and $3.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4.78%. The company achieved an average annual earnings per share of 48.57%. With a float of $34.56 million, this company’s outstanding shares have now reached $39.24 million.
Rani Therapeutics Holdings Inc (RANI) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rani Therapeutics Holdings Inc is 27.84%, while institutional ownership is 12.02%. The most recent insider transaction that took place on Dec 13 ’24, was worth 29,993. In this transaction Chief Business Officer of this company bought 17,960 shares at a rate of $1.67, taking the stock ownership to the 17,960 shares. Before that another transaction happened on Dec 09 ’24, when Company’s Chief Executive Officer bought 10,296 for $1.94, making the entire transaction worth $19,974. This insider now owns 494,751 shares in total.
Rani Therapeutics Holdings Inc (RANI) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.24 earnings per share (EPS) for the period topping the consensus outlook (set at -0.29) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.74% during the next five years compared to 4.78% growth over the previous five years of trading.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Rani Therapeutics Holdings Inc (RANI) is currently performing well based on its current performance indicators. A quick ratio of 0.54 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Looking closely at Rani Therapeutics Holdings Inc (NASDAQ: RANI), its last 5-days average volume was 0.66 million, which is a drop from its year-to-date volume of 1.18 million. As of the previous 9 days, the stock’s Stochastic %D was 67.79%.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 23.21%, which indicates a significant decrease from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0414 in the past 14 days, which was lower than the 0.0692 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5296, while its 200-day Moving Average is $1.1841. However, in the short run, Rani Therapeutics Holdings Inc’s stock first resistance to watch stands at $0.6492. Second resistance stands at $0.6739. The third major resistance level sits at $0.7235. If the price goes on to break the first support level at $0.5749, it is likely to go to the next support level at $0.5253. Now, if the price goes above the second support level, the third support stands at $0.5006.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
Market capitalization of the company is 29.91 million based on 71,869K outstanding shares. Right now, sales total 1,030 K and income totals -30,020 K. The company made 170 K in profit during its latest quarter, and -7,260 K in sales during its previous quarter.
